Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Business Update

Dr. Reddy's Laboratories Business Update

Dr. Reddy's Laboratories received a USFDA Form 483 with two observations following a Pre-Approval Inspection at its Pydibhimavaram facility. The company plans to address these observations within the stipulated timeline.

Source

BSE filing, NSE: DRREDDY. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Dr. Reddy's Laboratories Ltd: key numbers

Share price
₹1,335.40
Market cap
₹1,11,463 Cr
Revenue (annual)
₹33,700 Cr
Net profit (annual)
₹4,196 Cr
P/E (TTM)
39.8×Sector 46.1×
Promoter holding
26.63%-0.01% QoQ
FII holding
20.30%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Dr. Reddy's Laboratories Ltd

All →

Other business update announcements

All →